Company Profiles

driven by the PitchBook Platform

Torax Medical

Torax Medical
2002 FOUNDED
M&A STATUS
71-80 EMPLOYEES
M&A LATEST DEAL TYPE
Description

Developer and manufacturer of medical devices designed for the treatment of diseases gastroesophageal reflux disease, or GERD. The company's products, apply the unique properties of specialized magnets to precisely restore the barrier functions of sphincters through minimally invasive procedures.

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-Backed
Primary Industry
Surgical Devices
Other Industries
Therapeutic Devices
Parent Company
Primary Office
4188 Lexington Avenue North
Shoreview, MN 55126
United States

+1 (651) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Torax Medical’s full profile, request a free trial.

Torax Medical Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Merger/Acquisition 23-Mar-2017 00000 Completed Generating Revenue
8. Later Stage VC (Series E) 25-Jul-2016 0000 00000 00000 Completed Generating Revenue
7. Debt - General 01-Oct-2014 0000 000.00 Completed Generating Revenue
6. Later Stage VC (Series D) 13-Dec-2013 0000 000.00 00000 Completed Generating Revenue
5. Convertible Debt 31-May-2011 000 000.00 Completed Generating Revenue
4. Grant 31-Dec-2009 00000 000.00 Completed Generating Revenue
3. Later Stage VC (Series C) 14-Jun-2009 000.00 000.00 000.00 Completed Generating Revenue
2. Early Stage VC (Series B) 28-Jun-2005 $13.2M $16.7M 000.00 Completed Startup
1. Early Stage VC (Series A) 21-Feb-2004 $3.5M $3.5M 000.00 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Torax Medical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series E 00,000,000 00.000000 00 00.00 00.00 00 00.00 000
Series D 00,000,000 00.000000 00 00.00 00.00 00 00.00 000
Series C 00,000,000 00.000000 00 00.0 00.0 00 00.0 00.000
Series B 11,954,546 $0.001000 8% $1.1 $1.1 1x $1.1 11.95%
Series A 4,117,648 $0.001000 8% $0.85 $0.85 1x $0.85 4.12%
To view this company’s complete Cap Table, request access »

Torax Medical Former Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Accuitive Medical Ventures Venture Capital Minority 000 0000 000000 0
Johnson & Johnson Innovation - JJDC Corporate Venture Capital Minority 000 0000 000000 0
Kaiser Permanente Ventures Corporate Venture Capital Minority 000 0000 000000 0
Mayo Clinic Ventures Corporate Venture Capital Minority 000 0000 000000 0
Piper Jaffray Investment Bank Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »

Torax Medical Executive Team (17)

Name Title Board
Seat
Contact
Info
Charles McKhann Chief Commercial Officer
Kirk Ellis Vice President of Sales US & Sales Manager
Steve Bosrock Senior Director of Marketing & Vice President of LINX U.S. Marketing
Brian Scovil Senior Vice President of R&D, Ops, Quality and Regulatory
Simon Freedman Vice President

9 Former Executives

You’re viewing 5 of 17 executives. Get the full list »
Questions or concerns about this profile? Reach out to website-support@pitchbook.com